| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $247.24B | $249.71B | $254.91B |
| YoY Revenue Growth % | -1.0% | -2.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $79.02B | $105.01B | $113.54B |
| Operating Margin % | 32.0% | 42.1% | 44.5% |
| Net Income (GAAP) | $66.97B | $89.00B | $96.22B |
| EBITDA (Normalized) | $95.76B | $120.19B | $122.72B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $45.97B | $30.59B | $49.20B |
| Capital Expenditures (CapEx) | $20.93B | $18.98B | $11.47B |
| Free Cash Flow (FCF) | $25.04B | $11.62B | $37.73B |
| FCF Margin % | 10.1% | 4.7% | 14.8% |
| Return on Invested Capital (ROIC %) | 7.7% | 11.1% | 22.5% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $226.11B | $226.00B | $154.75B |
| Total Stockholders' Equity | $717.42B | $649.37B | $317.44B |